While there have always been climatic and cultural differences in nutrition, it took the discoveries of modern medicine to know what our bodies are truly lacking
Table 14: Results at Week 26 in a Trial Comparing TRESIBA to Sitagliptin in Adult Patients with Type 2 Diabetes Mellitus on OADs* Safety Outcomes Trial DEVOTE (NCT01959529) Cardiovascular Outcomes Trial Of TRESIBA Administered Once Daily Between Dinner And Bedtime In Combination With Standard Of Care In Subjects With Type 2 Diabetes And Atherosclerotic Cardiovascular Disease DEVOTE was a multi center, multi national, randomized, double blinded, active controlled, treat to target, event driven trial
Staying hydrated is essential, along with light physical activity to promote digestion
Choose your injection site Most people prefer to inject Ozempic in the stomach area, but it can also be injected in the upper thigh or upper arm
The SURMOUNT-1 trial demonstrated significant weight loss, with patients losing approximately 15-21% of their body weight at the 15 mg dose over 72 weeks, depending on the statistical method used
In the SURMOUNT-1 trial, participants without diabetes lost an average of 15-20% of their body weight over 72 weeks at the 10 mg and 15 mg doses, though results may vary in different populations
